Foscavir/Cytovene study
Executive Summary
Comparison trial of Astra's Foscavir (foscarnet) and Syntex' Cytovene (ganciclovir) in the treatment of cytomegalovirus retinitis is being sponsored by the National Eye Institute, not Astra ("The Pink Sheet" June 17, p. 18). The firms are supplying the drugs used in the trial, which is part of an NEI program known as SOCA (Studies of the Ocular Complications of AIDS).